Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Andrology ; 9(1): 80-87, 2021 01.
Article in English | MEDLINE | ID: mdl-32960504

ABSTRACT

In lately December 2019, a novel coronavirus (SARS-CoV-2) outbreak occurred in Wuhan, PR China. It is a high contagious virus that has threatened human health worldwide. SARS-CoV-2 infection, termed COVID-19, causes rapidly developing lung lesions that can lead to multiple organ failure in a short period. Whenever a novel virus emerges, reproductive risk assessments should be performed after infection. In this review, we show that male fertility might be damaged by coronavirus associated with (i) direct cytopathic effects derived from viral replication and viral dissemination in the testis; and (ii) indirect damage to male fertility derived from immunopathology. In this review, we briefly describe the impaired fertility of humans and animals infected with coronaviruses to deduce the impact of the new coronavirus on male fertility. Together with information related to other coronaviruses, we extrapolate this knowledge to the new coronavirus SARS-CoV-2, which may have a significant impact on our understanding of the pathophysiology of this new virus.


Subject(s)
Fertility , Infertility, Male/virology , Reproductive Health , Urogenital System/virology , Animals , Host-Pathogen Interactions , Humans , Infertility, Male/diagnosis , Infertility, Male/physiopathology , Male , Prognosis , Risk Assessment , Risk Factors , Sex Factors , Urogenital System/physiopathology
2.
Andrology ; 9(1): 73-79, 2021 01.
Article in English | MEDLINE | ID: mdl-32869939

ABSTRACT

BACKGROUND: The current outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, named coronavirus disease 19 (COVID-19), is not the first well-known spillover of an animal originated virus to infect humans. However, one of the few to make such a fast jump in a powerful evolutionary shortcut. The incredible pattern of aggressiveness worldwide since the beginning of the outbreak is that up to 20% of those infected need hospitalization and 5% evolve to critical conditions, not limited to respiratory-related issues, but rather to systemic involvement. OBJECTIVE: This study aims to summarize the current knowledge about the effects of SARS-CoV-2 infection on the male genitourinary tract. MATERIALS AND METHODS: A narrative review was carried out to identify articles on the SARS-CoV-2 infection on the male genitourinary system. RESULTS: Considerations were made about the molecular characteristics of SARS-CoV-2 and immune response to coronavirus. We discussed the influence of the virus on the urinary system, potential mechanisms of COVID-19- related acute kidney injury (AKI), and the role of cytokine release syndrome on the renal pathophysiology of the disease. In the male reproductive tract, it was discussed the testis' vulnerability to SARS-CoV-2 invasion and the possible adverse effects on its function and the seminal findings of COVID-19. DISCUSSION AND CONCLUSION: During the COVID-19 pandemic, an international coordinated scientific effort must arise to understand the role of the urogenital system in the SARS-CoV-2 infection in the clinical setting.


Subject(s)
COVID-19/virology , Fertility , Infertility, Male/virology , Reproductive Health , SARS-CoV-2/pathogenicity , Urogenital System/virology , Animals , COVID-19/diagnosis , Host-Pathogen Interactions , Humans , Infertility, Male/diagnosis , Infertility, Male/physiopathology , Male , Prognosis , Risk Assessment , Risk Factors , Sex Factors , Urogenital System/physiopathology
3.
Biomed Pharmacother ; 127: 110195, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32361161

ABSTRACT

Since early December 2019, a number of pneumonia cases associated with unknown coronavirus infection were identified in Wuhan, China, and many additional cases were identified in other regions of China and in other countries within 3 months. Currently, more than 80,000 cases have been diagnosed in China, including more than 3000 deaths. The epidemic is spreading to the rest of the world, posing a grave challenge to prevention and control. On February 12, 2020, the International Committee on Taxonomy of Viruses and the World Health Organization officially named the novel coronavirus and associated pneumonia as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19), respectively. According to the recent research on SARS-CoV-2, the virus mainly infects the respiratory system but may cause damage to other systems. In this paper, we will systematically review the pathogenic features, transmission routes, and infection mechanisms of SARS-CoV-2, as well as any adverse effects on the digestive system, urogenital system, central nervous system, and circulatory system, in order to provide a theoretical and clinical basis for the diagnosis, classification, treatment, and prognosis assessment of SARS-CoV-2 infection.


Subject(s)
Betacoronavirus , Cardiovascular System/virology , Central Nervous System/virology , Coronavirus Infections , Digestive System/virology , Multiple Organ Failure , Pandemics , Pneumonia, Viral , Urogenital System/virology , Betacoronavirus/isolation & purification , Betacoronavirus/pathogenicity , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/physiopathology , Coronavirus Infections/therapy , Coronavirus Infections/transmission , Disease Management , Humans , Multiple Organ Failure/prevention & control , Multiple Organ Failure/virology , Pneumonia, Viral/epidemiology , Pneumonia, Viral/physiopathology , Pneumonia, Viral/therapy , Pneumonia, Viral/transmission , SARS-CoV-2
6.
Virology ; 535: 1-10, 2019 09.
Article in English | MEDLINE | ID: mdl-31254742

ABSTRACT

Prior to the emergence of Asian genotype Zika virus (ZIKV) in the Western hemisphere, sexual transmission in humans was documented. Sexual transmission by African genotype ZIKVs has not been assessed in laboratory animal models, due to rapid and high mortality rates of immunodeficient mice following inoculation. To overcome these limitations, immunocompetent C57Bl/6 mice were used to longitudinally assess Asian and African genotype ZIKV sexual transmission potential. Furthermore, to determine if enhanced pathogenesis of African genotype ZIKVs is due to structural determinants, PRVABC59 prM/E was replaced with African MR766 prM/E (chimeric ZIKV). The African genotype and chimeric ZIKV elicited greater pathogenic effects in the male reproductive tract and generated higher viremias. Yet, the duration, magnitude and efficiency of seminal shedding of infectious virus and viral RNA were similar between chimeric-, African and Asian genotype ZIKV-inoculated mice. These data show that increased male reproductive tract pathology does not increase sexual transmission potential.


Subject(s)
Disease Transmission, Infectious , RNA, Viral/isolation & purification , Sexually Transmitted Diseases, Viral/transmission , Virus Shedding , Zika Virus Infection/transmission , Zika Virus/growth & development , Animals , Disease Models, Animal , Female , Genotype , Longitudinal Studies , Male , Mice, Inbred C57BL , Reproductive Tract Infections/virology , Sexually Transmitted Diseases, Viral/virology , Urogenital System/virology , Zika Virus/genetics , Zika Virus/pathogenicity , Zika Virus Infection/pathology , Zika Virus Infection/virology
7.
BMC Infect Dis ; 19(1): 65, 2019 Jan 17.
Article in English | MEDLINE | ID: mdl-30654754

ABSTRACT

BACKGROUND: Herpes simplex virus (HSV) has various presentations, depending on the patient's immune status, age, and the route of transmission. In adults, HSV type 1 is found predominantly in the oral area, and HSV type 2 (HSV-2) is commonly found in the genital area. HSV-2 infection without genital lesions is uncommon. Herein we report a unique case of pharyngotonsillitis as an initial manifestation of disseminated HSV-2 infection without genital involvement. CASE PRESENTATION: A 46-year-old male was admitted to our hospital with a 1-week history of fever and sore throat. His past medical history included hypereosinophilic syndrome diagnosed at age 45 years. Physical examination revealed throat congestion, bilaterally enlarged tonsils with exudates, tender cervical lymphadenopathy in the left posterior triangle, and mild epigastric tenderness. The laboratory data demonstrated bicytopenia, elevated liver enzyme levels, and hyperferritinemia. A bone marrow smear showed hypocellular marrow with histiocytes and hemophagocytosis. The diagnosis of HLH was confirmed, and the patient was treated with methylprednisolone pulse therapy on days 1-3. On day 5, despite initial improvement of the fever and sore throat, multiple, new, small bullae developed on the patient's face, trunk, and extremities. Additional testing showed that he was positive for HSV-specific immunoglobulin M and immunoglobulin G. Disseminated HSV infection was suspected, and intravenous acyclovir (10 mg/kg every 8 h) was begun. A subsequent direct antigen test of a bulla sample was positive for HSV-2. Moreover, tonsillar and esophageal biopsies revealed viral inclusion bodies. Immunohistochemical staining and a quantitative real-time polymerase chain reaction (PCR) assay confirmed the presence of HSV-2. Disseminated HSV-2 infection with multiple bullae, tonsillitis, esophagitis, and suspected hepatic involvement was diagnosed. After a 2-week course of intravenous acyclovir, his hematological status and liver function normalized, and his cutaneous skin lesions resolved. He was discharged on day 22 in good general health and continued taking oral valacyclovir for viral suppression due to his immunosuppressed status. CONCLUSION: Disseminated HSV-2 infection should be considered as one of the differential diagnoses in patients with pharyngotonsillitis and impaired liver function of unknown etiology even if there are no genital lesions.


Subject(s)
Esophagitis/diagnosis , Herpes Simplex/diagnosis , Herpesvirus 2, Human/isolation & purification , Lymphohistiocytosis, Hemophagocytic/diagnosis , Tonsillitis/diagnosis , Acyclovir/therapeutic use , Esophagitis/complications , Esophagitis/drug therapy , Esophagitis/virology , Herpes Simplex/complications , Herpes Simplex/drug therapy , Herpes Simplex/virology , Humans , Immunocompromised Host , Lymphohistiocytosis, Hemophagocytic/complications , Lymphohistiocytosis, Hemophagocytic/drug therapy , Lymphohistiocytosis, Hemophagocytic/virology , Male , Middle Aged , Pharyngitis/diagnosis , Pharyngitis/drug therapy , Pharyngitis/virology , Tonsillitis/complications , Tonsillitis/drug therapy , Tonsillitis/virology , Urogenital System/virology
8.
Dev Comp Immunol ; 82: 177-185, 2018 05.
Article in English | MEDLINE | ID: mdl-29382557

ABSTRACT

Infectious diseases are contributing to the decline of the iconic Australian marsupial, the koala (Phascolarctos cinereus). Infections with the obligate intracellular bacteria, Chlamydia pecorum, cause debilitating ocular and urogenital-tract disease while the koala-retrovirus (KoRV) has been implicated in host immunosuppression and exacerbation of chlamydial pathogenesis. Although histological studies have provided insight into the basic architecture of koala immune tissues, our understanding of the koala immune response to infectious disease has been limited, until recently, by a lack of species-specific immune reagents. Recent advances in the characterisation of key immune genes have focused on advancing our understanding of the immune response to Chlamydia infection, revealing commonalities in disease pathologies and immunity between koalas and other hosts and paving the way for the development of a koala Chlamydia vaccine. This review summarises these recent findings and highlights key aspects of the koala immune system requiring further attention with particular regard to their most prominent infectious diseases.


Subject(s)
Chlamydia Infections/immunology , Chlamydia/physiology , Communicable Diseases/immunology , Phascolarctidae/immunology , Retroviridae Infections/immunology , Retroviridae/physiology , Urogenital System/immunology , Animals , Australia , Bacterial Vaccines/immunology , Host-Pathogen Interactions , Humans , Immunity/genetics , Immunosuppression Therapy , Urogenital System/microbiology , Urogenital System/virology
9.
Andrology ; 2(5): 687-94, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24903066

ABSTRACT

Acute and chronic infections of the seminal tract are among the most common causes of male infertility. As at least half of male infertility cases are classified as idiopathic, some of these cases might be attributed to asymptomatic infection. The detection and quantification of Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human herpes virus type 6 (HHV-6) DNA in semen samples were performed. A total of 232 patients were divided into five groups: (i) infertile men with varicocoele; (ii) men with idiopathic infertility; (iii) infertile men with chronic inflammatory urogenital tract diseases (IUTD); (iv) fertile men with IUTD and (v) men whose partners had a history of pregnancy loss. In the study population, the prevalence of viral DNA was 17.7, 3.4% for EBV, 5.2% for CMV, 6.5% for HHV-6, 0.43% for EBV + CMV, 0.87% for EBV + HHV-6 and 1.3% for CMV + HHV-6. The median viral loads for EBV, CMV and HHV-6 were 500, 2250 and 250 copies/mL respectively. Of the sperm cell fractions, derived from infected samples 87.5% contained viral DNA. No association between EBV and fertility disorders or IUTD was found. CMV detection was much higher in the group of patients with infertility and concomitant IUTD compared with the other groups combined (18.5% vs. 5.4%, p = 0.03) and associated with reduced sperm cell count (39.5 × 10(6) /mL vs. 72.5 × 10(6) /mL, p = 0.036). Immunostaining of spermatozoa from infected samples and in vitro-infected cells detected CMV in sperm heads, tails and connecting pieces and revealed attachment to sperm membrane and intracellular localization. HHV-6 was the more common in fertile men with chronic IUTD than in the other groups combined (19% vs. 6.3%, p = 0.018) and had no effect on sperm parameters. The results suggest that both CMV and HHV-6 may contribute to the aetiology of IUTD and, moreover, CMV-associated IUTD can lead to male sterility.


Subject(s)
DNA, Viral/isolation & purification , Herpesviridae Infections/virology , Infertility, Male/virology , Male Urogenital Diseases/virology , Adult , Cytomegalovirus/isolation & purification , Herpesvirus 4, Human/isolation & purification , Herpesvirus 6, Human/isolation & purification , Humans , Male , Semen Analysis , Spermatozoa/virology , Urogenital System/virology , Varicocele
10.
Article in Russian | MEDLINE | ID: mdl-25816522

ABSTRACT

AIM: Determine the ability of Corynebacterium non diphtheriae to induce phagocytosis and apoptosis of macrophages and evaluate regulatory effect of nuetrophilokines (NPK) induced by Corynebacterium non diphtheriae on these processes. MATERIALS AND METHODS: The ability of Corynebacterium non diphtheriae, isolated from upper respiratory tract, skin and urogenital tract (UGT) were studied for the ability to induce phagocytosis and apoptosis of mice macrophages (MP; in vitro during staining by May-Grunwald with additional staining by Romanowsky-Giemsa) before and after the addition of NPK induced by Corynebacterium non diphtheriae. RESULTS: Phagocytic index (PI) was the same for all the Corynebacterium non diphtheriae species, phagocytic number (PN) and index of phagocytosis completion (IPC)--were minimal relative to corynebacteria isolated from UGT. All the studied corynebacteria species induced MP apoptosis; the most pronounced apoptogenic effect was detected in Corynebacterium pseudotuberculosis isolated from UGT. NPK increased PN against corynebacteria isolated from the studied biotopes, IPC--only during studies of corynebacteria isolated from skin. The effect of NPK resulted in a reduction of apoptogenic effect for almost all the Corynebacterium non diphtheriae, regardless of the isolation location. CONCLUSION: A pronounced apoptogenic effect and insufficiency of phagocytosis processes induced by corynebacteria are the means of realization of Corynebacterium non diphtheriae pathogenic effect. NPK use is possible for immune correction of immune deficiency conditions developing against the background of diseases determined by Corynebacterium non diphtheriae.


Subject(s)
Apoptosis , Corynebacterium pseudotuberculosis/pathogenicity , Macrophages, Peritoneal/microbiology , Respiratory System/microbiology , Skin/microbiology , Urogenital System/microbiology , Animals , Corynebacterium pseudotuberculosis/growth & development , Corynebacterium pseudotuberculosis/isolation & purification , Humans , Mice , Phagocytosis , Primary Cell Culture , Respiratory System/immunology , Respiratory System/virology , Skin/immunology , Skin/virology , Urogenital System/immunology , Urogenital System/virology
11.
Intervirology ; 56(6): 395-412, 2013.
Article in English | MEDLINE | ID: mdl-24157886

ABSTRACT

Viruses are the most abundant obligate intracellular entities in our body. Until recently, they were only considered to be pathogens that caused a broad array of pathologies, ranging from mild disease to deaths in the most severe cases. However, recent advances in unbiased mass sequencing techniques as well as increasing epidemiological evidence have indicated that the human body is home to diverse viral species under non-pathological conditions. Despite these studies, the description of the presumably healthy viral flora, i.e. the normal human virome, is still in its infancy regarding viral composition and dynamics. This review summarizes our current knowledge of the human virome under non-pathological conditions.


Subject(s)
Microbiota , Viruses/classification , Viruses/isolation & purification , Blood/virology , Gastrointestinal Tract/virology , Humans , Nervous System/virology , Respiratory System/virology , Skin/virology , Urogenital System/virology
12.
FEMS Microbiol Rev ; 37(5): 762-92, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23789590

ABSTRACT

The urogenital tract appears to be the only niche of the human body that shows clear differences in microbiota between men and women. The female reproductive tract has special features in terms of immunological organization, an epithelial barrier, microbiota, and influence by sex hormones such as estrogen. While the upper genital tract is regarded as free of microorganisms, the vagina is colonized by bacteria dominated by Lactobacillus species, although their numbers vary considerably during life. Bacterial vaginosis is a common pathology characterized by dysbiosis, which increases the susceptibility for HIV infection and transmission. On the other hand, HIV infections are often characterized by a disturbed vaginal microbiota. The endogenous vaginal microbiota may protect against HIV by direct production of antiviral compounds, through blocking of adhesion and transmission by ligands such as lectins, and/or by stimulation of immune responses. The potential role of probiotics in the prevention of HIV infections and associated symptoms, by introducing them to the vaginal and gastrointestinal tract (GIT), is also discussed. Of note, the GIT is a site of considerable HIV replication and CD4(+) T-cell destruction, resulting in both local and systemic inflammation. Finally, genetically engineered lactobacilli show promise as new microbicidal agents against HIV.


Subject(s)
HIV Infections/microbiology , HIV Infections/transmission , Microbiota , Urogenital System/microbiology , Vagina/microbiology , Animals , Female , Host-Pathogen Interactions , Humans , Male , Urogenital System/immunology , Urogenital System/virology , Vagina/immunology , Vagina/virology
13.
Article in German | MEDLINE | ID: mdl-22138800

ABSTRACT

OBJECTIVE: The detection rate of various viral and bacterial agents causing reproductive failure in sows was analysed. MATERIAL AND METHODS: Samples from abortion/uterus (n=714), sera from weak born piglets (n=317), cervical swabs (n=881) and urogenital organs from slaughtered sows (n=416) that had been submitted between January 2006 and June 2009 were included in this analysis. Various PCR assays were run to detect PRRSV, PCV2, PPV, Chlamydia spp. and Leptospira spp. Other bacterial agents were examined using standard cultural methods. RESULTS: In material from abortion, detection rates of 14.7% for PCV2 and 6.8% for PRRSV EU genotype were revealed using PCR screening. The other agents were detected in single cases only (PPV 2.2%, PRRSV US genotype 1.8%, Chlamydia spp. 1.0%, Leptospira spp. 0.8%). Single PCR yielded a significantly higher detection rate for PCV2 than PCR screening. Comparing results from abortion/uterus and serum samples from weak born piglets, a significantly higher detection rate of PCV2 and PRRSV was found in sera. Bacteriological examination revealed bacterial agents in more than 75% of all cervical swabs. However, half of them had to be considered as contaminated due to the diversity of the isolated bacteria. Bacteriological testing of urogenital organs from slaughtered sows yielded positive results in 60% of all samples, with a remarkably lower proportion of contaminated samples of 7.4%. CONCLUSION: It is assumed that 60-70% of all cases of reproductive failure are similarly not caused by primary infections. If PRRSV infection is suspected, examination of serum samples from weak born piglets is much better than the testing of foetuses or other material from abortion. Due to poor detection rates, the examination of foetuses/abortion material by screening PCR cannot be recommended. In the case of bacterial infections of the urogenital system, the cultural examination of organs from slaughtered sows is more often successful than the testing of cervical swabs.


Subject(s)
Abortion, Veterinary/microbiology , Swine Diseases/microbiology , Abortion, Veterinary/virology , Animals , Cervix Uteri/microbiology , Cervix Uteri/virology , Chlamydia/isolation & purification , Circovirus/isolation & purification , Female , Leptospira/isolation & purification , Parvovirus, Porcine/isolation & purification , Porcine Reproductive and Respiratory Syndrome/diagnosis , Porcine respiratory and reproductive syndrome virus/isolation & purification , Retrospective Studies , Swine , Swine Diseases/virology , Urogenital System/microbiology , Urogenital System/virology , Uterus/microbiology , Uterus/virology
14.
Adv Dent Res ; 23(1): 38-44, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21441479

ABSTRACT

The AIDS pandemic continues. Little is understood about how HIV gains access to permissive cells across mucosal surfaces, yet such knowledge is crucial to the development of successful topical anti-HIV-1 agents and mucosal vaccines. HIV-1 rapidly internalizes and integrates into the mucosal keratinocyte genome, and integrated copies of HIV-1 persist upon cell passage. The virus does not appear to replicate, and the infection may become latent. Interactions between HIV-1 and oral keratinocytes have been modeled in the context of key environmental factors, including putative copathogens and saliva. In keratinocytes, HIV-1 internalizes within minutes; in saliva, an infectious fraction escapes inactivation and is harbored and transferable to permissive target cells for up to 48 hours. When incubated with the common oral pathogen Porphyromonas gingivalis, CCR5- oral keratinocytes signal through protease-activated receptors and Toll-like receptors to induce expression of CCR5, which increases selective uptake of infectious R5-tropic HIV-1 into oral keratinocytes and transfer to permissive cells. Hence, oral keratinocytes-like squamous keratinocytes of other tissues-may be targets for low-level HIV-1 internalization and subsequent dissemination by transfer to permissive cells.


Subject(s)
HIV Infections/physiopathology , HIV-1/physiology , Keratinocytes/virology , Mouth Mucosa/virology , Virus Internalization , Virus Replication , Animals , Dendritic Cells/virology , Humans , Immunity, Mucosal , Mouth Mucosa/cytology , Porphyromonas gingivalis/physiology , Receptors, CCR5/physiology , Receptors, CXCR/physiology , Superinfection/physiopathology , Urogenital System/virology , Virus Latency
15.
Sex Transm Infect ; 87(3): 232-7, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21278399

ABSTRACT

OBJECTIVES: Genitourinary tract samples are required to investigate male HIV-1 infectivity. Because semen collection is often impractical, the acceptability, feasibility and validity of post-prostatic massage fluid/urine (post-PMF/U) was evaluated for studying male genitourinary HIV-1 shedding. METHODS: HIV-1-seropositive men were evaluated after 48 h of sexual abstinence. At each visit, a clinician performed prostatic massage, then post-PMF/U and blood were collected. Participants provided semen specimens 1 week later. An audio computer-assisted self-interview (ACASI) administered after each specimen collection evaluated acceptability, adherence to instructions and recent genitourinary symptoms. HIV-1 RNA was quantified using a real-time PCR assay. Detection and quantitation of HIV-1 RNA and stability over visits were compared for semen, post-PMF/U and blood. RESULTS: Post-PMF/U was successfully obtained at 106 visits (64%) and semen at 136 visits (81%, p<0.001). In ACASI, discomfort was rated higher for post-PMF/U collection (p=0.003), but there was no significant difference in acceptability. Detection of HIV-1 RNA in post-PMF/U was associated with detection in semen (p=0.02). Semen and post-PMF/U HIV-1-RNA levels were correlated (ρ=0.657, p<0.001). Concordance of results at repeat visits was 78.9% for post-PMF/U (κ=0.519, p=0.02) and 89.5% for both blood and semen (κ=0.774, p=0.001). CONCLUSIONS: Although semen collections were more successful, both post-PMF/U and semen collections were acceptable to many participants. HIV-1 RNA detection and levels were closely associated in semen and post-PMF/U, and results were relatively stable across visits. To assess male HIV-1 infectivity, post-PMF/U may represent a valid alternative when semen cannot be obtained.


Subject(s)
HIV Infections/virology , HIV-1 , Massage , Semen/virology , Urogenital System/virology , Virus Shedding , Adult , Bodily Secretions , Feasibility Studies , Humans , Male , Middle Aged , Prognosis , Prostate , RNA, Viral/analysis
16.
Am J Reprod Immunol ; 65(3): 308-16, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21214660

ABSTRACT

Despite several decades of clinical trials assessing the impact of etiological treatment of sexually transmitted diseases (STDs) to decrease HIV acquisition and transmission, almost all of these trials have not proven to be efficacious. Increasing evidence suggests that specific STD treatment alone may not be sufficient to alter the genital tract inflammatory milieu that is created by STDs. This paper examines the associations between STDs and HIV susceptibility and infectiousness, and considers the role of chronic and refractory inflammation to create an environment that potentiates HIV and STD transmission and acquisition by reviewing biological, observational, and clinical trial data.


Subject(s)
HIV Infections/transmission , Sexually Transmitted Diseases , Urogenital System , Antiretroviral Therapy, Highly Active , Disease Susceptibility , Drug Interactions , HIV Infections/immunology , HIV Infections/prevention & control , Humans , Inflammation , Sexually Transmitted Diseases/drug therapy , Sexually Transmitted Diseases/immunology , Sexually Transmitted Diseases/transmission , Urogenital System/immunology , Urogenital System/microbiology , Urogenital System/virology
17.
Am J Reprod Immunol ; 65(3): 248-52, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21223423

ABSTRACT

PROBLEM: Inductive and effector functions in the human mucosal immune system in relationship to protective immunity to HIV are poorly defined. METHOD OF STUDY: A broader review of vaccine-induced immunity in mucosal systems was undertaken. RESULTS: A series of questions are posed. The limited answers to the questions indicate our profound lack of knowledge of some of the broader issues of the induction of mucosal immunity. The questions posed include the following: Is there a common mucosal immune system? Is IgA the critical immunoglobulin class in mucosal protection? Will systemic administration of antigen stimulate mucosal immunity? Is there true sterilizing mucosal immunity? What is the duration of mucosal immunity? CONCLUSION: The focus on mucosal immunity in HIV of this conference highlights recent remarkable advances in our understanding of the early events in HIV pathogenesis at the mucosal surface. This review identifies areas for further research.


Subject(s)
HIV Infections/immunology , HIV/immunology , Immunity, Humoral , Immunity, Mucosal , Immunoglobulin A/immunology , Mucous Membrane/immunology , Female , HIV/pathogenicity , HIV Antibodies/immunology , Humans , Male , Urogenital System/immunology , Urogenital System/virology , Viral Vaccines/immunology
18.
J Invertebr Pathol ; 102(3): 225-32, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19686757

ABSTRACT

To demonstrate pathological changes due to white spot virus infection in Fenneropenaeus indicus, a batch of hatchery bred quarantined animals was experimentally infected with the virus. Organs such as gills, foregut, mid-gut, hindgut, nerve, eye, heart, ovary and integument were examined by light and electron microscopy. Histopathological analyses revealed changes hitherto not reported in F. indicus such as lesions to the internal folding of gut resulted in syncytial mass sloughed off into lumen, thickening of hepatopancreatic connective tissue with vacuolization of tubules and necrosis of rectal pads in hindgut. Virus replication was seen in the crystalline tract region of the compound eye and eosinophilic granules infiltrated from its base. In the gill arch, dilation and disintegration of median blood vessel was observed. In the nervous tissues, encapsulation and subsequent atrophy of hypertrophied nuclei of the neurosecretory cells were found. Transmission electron microscopy showed viral replication and morphogenesis in cells of infected tissue. De novo formed vesicles covered the capsid forming a bilayered envelop opened at one end inside the virogenic stroma. Circular vesicles containing nuclear material was found fused with the envelop. Subsequent thickening of the envelop resulted in the fully formed virus. In this study, a correlation was observed between the stages of viral multiplication and the corresponding pathological changes in the cells during the WSV infection. Accordingly, gill and foregut tissues were found highly infected during the onset of clinical signs itself, and are proposed to be used as the tissues for routine disease diagnosis.


Subject(s)
Penaeidae/virology , White spot syndrome virus 1/physiology , Animals , Cardiovascular System/ultrastructure , Cardiovascular System/virology , Digestive System/ultrastructure , Digestive System/virology , Eye/ultrastructure , Eye/virology , Nervous System/virology , Penaeidae/ultrastructure , Urogenital System/ultrastructure , Urogenital System/virology , Virus Replication , White spot syndrome virus 1/ultrastructure
19.
Cancer Epidemiol Biomarkers Prev ; 18(4): 1077-83, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19318438

ABSTRACT

Human papillomavirus (HPV) causes cervical cancer and is strongly associated with other anogenital cancers. Multiple-type HPV infection has been associated with lengthier infection and precancerous lesions. Little is known about multiple-type HPV prevalence and associated factors in men. We examined the prevalence of and risk factors for multiple-type HPV in primarily asymptomatic men. Detection of 37 HPV types in male anogenital epithelium and semen was completed in 463 men in two U.S. cities. The proportions of men with multiple HPV of any type and with multiple oncogenic or nononcogenic types were calculated. Factors associated with multiple HPV were evaluated using multinomial logistic regression. Overall, 22.9% of men had multiple-HPV, 8.6% of men had multiple oncogenic types, and 13.4% had multiple nononcogenic types. Greater proportions of samples at the shaft, glans/corona, and scrotum had multiple HPV types (18.7%, 12.8%, and 7.3%, respectively) than did other anogenital sites (all < or =2.8%). Factors independently associated with multiple-type HPV were Hispanic ethnicity [adjusted odds ratio (AOR), 2.45; 95% confidence interval (95% CI), 1.05-5.67], concurrent detection of genital warts (AOR, 10.40; 95% CI, 1.12-96.6), smoking > or =10 cigarettes/d (AOR, 3.00; 95% CI, 1.07-8.43), greater lifetime number of female sexual partners (AOR, 13.73 for > or =21 versus 1-5; 95% CI, 5.34-35.3), and condom use less than half the time (AOR, 2.03; 95% CI, 1.07-3.84). Detection of multiple HPV types in this study of primarily asymptomatic men was common, particularly at external genital sites. Lifetime number of female sex partners, condom use, and smoking were modifiable factors associated with multiple HPV.


Subject(s)
Anal Canal/virology , Papillomaviridae/classification , Papillomaviridae/isolation & purification , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Urogenital System/virology , Adolescent , Adult , Condylomata Acuminata/epidemiology , Condylomata Acuminata/virology , Cross-Sectional Studies , Humans , Male , Prevalence , Risk Factors , Semen/virology , Young Adult
20.
Cancer Epidemiol Biomarkers Prev ; 16(6): 1107-14, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17548671

ABSTRACT

BACKGROUND: Human papillomavirus (HPV) is sexually transmitted and causes cervical cancer. Although HPV can infect men and women, little is known about infection in men. Specifically, the prevalence of type-specific HPV infection and the distribution of infections by anogenital anatomic site in men are incompletely characterized. METHODS: We tested 463 men ages 18 to 40 years for HPV at the glans/corona, penile shaft, scrotum, urethra, perianal area, anal canal, and in a semen sample. Eligible men acknowledged no history of genital warts and had sexual intercourse with a woman within the past year. HPV testing by PCR and reverse line blot genotyping for 37 types was conducted on each of the specimens from the seven sampling sites. RESULTS: When HPV results from any sampling site were considered, 237 (51.2%) men were positive for at least one oncogenic or nononcogenic HPV type, and another 66 (14.3%) men were positive for an unclassified HPV type. The types with the highest prevalence were HPV-16 (11.4%) and 84 (10.6%). External genital samples (glans/corona, shaft, and scrotum) were more likely than anal samples to contain oncogenic HPV (25.1% versus 5.0%). HPV-positive penile shaft and glans/corona samples were also more likely to be infected with multiple HPV types than other sites. CONCLUSIONS: More complete anogenital sampling and sensitive detection for 37 HPV types resulted in a higher HPV prevalence in primarily asymptomatic men than reported previously. The penile shaft was the site most likely to be HPV positive and harbored the greatest proportion of multiple type and oncogenic infections. These results have implications for research of HPV among men and transmission between partners.


Subject(s)
Anal Canal/virology , Papillomavirus Infections/epidemiology , Semen/virology , Tumor Virus Infections/epidemiology , Urogenital System/virology , Adolescent , Adult , Cross-Sectional Studies , Humans , Male , Middle Aged , Papillomaviridae/isolation & purification , Polymerase Chain Reaction , Prevalence , Sexually Transmitted Diseases, Viral/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...